<DOC>
	<DOCNO>NCT00874835</DOCNO>
	<brief_summary>The purpose study determine whether surgical outcome patient undergo Descemet 's Stripping Endothelial Keratoplasty ( DSEK ) improve use insertion device traditional forceps insertion method .</brief_summary>
	<brief_title>Corneal Endothelium Delivery Instrument</brief_title>
	<detailed_description>Laboratory study clinical functionality test show study device safely forms tissue without crease folding . It allow allograft tissue safely pass anterior chamber without compression , crush , squeeze endothelial cell . The device provide continuous irrigation eye prevent collapse anterior chamber insertion . Our study focus safety efficacy novel instrument current method insertion ( forceps ) . FDA classified device Class I , Reserved .</detailed_description>
	<criteria>Patients Fuchs endothelial dystrophy bullous keratopathy determine need corneal transplant visual restoration .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Endothelial Keratoplasty</keyword>
	<keyword>EK</keyword>
	<keyword>Descemet Stripping Endothelial Keratoplasty</keyword>
	<keyword>Corneal Transplantation</keyword>
	<keyword>Keratoplasty</keyword>
	<keyword>DSEK</keyword>
	<keyword>DSAEK</keyword>
</DOC>